On October 5, 2026, Fullgoal Fund Management Co., Ltd. sold 132,000 H shares of BIOCYTOGEN-B on the SEHK open market at an average of HKD 70.5388 per share, involving approximately HKD 9.31 million. This is an on-exchange active trade, a direct secondary-market dealing.
Prior to the disposal, Fullgoal Fund Management's long position in BIOCYTOGEN-B was 9.99 million shares, representing 9.01%; following the disposal, the holding changed to 9.94 million shares, with the long position ratio falling to 8.98%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments